QPPV.COM KNOWLEDGE ASSESSMENT

Knowledge Assessment: Writing the PSUR Safety Evaluation

Test your understanding of the concepts covered by GVP Module VII: Writing the PSUR Safety Evaluation.

Question 1 of 10Pass mark: 80%

Question 1 of 10 A significant safety finding becomes available shortly after the data lock point. Which principle applies?

The finding must be ignored because the data lock point has passed The finding should automatically be inserted without regard to procedural controls The organisation should determine whether immediate or other regulatory action is needed and handle the information under applicable requirements and controlled procedures The finding can be deferred until the next PSUR in all circumstances

Question 2 of 10 Which feature is most relevant when characterising a rare but potentially fatal adverse reaction?

The low number of reports alone Only the reporting rate compared with other adverse reactions Clinical phenotype, seriousness, alternative explanations, temporality, plausibility, and supporting evidence Whether the event occurs more often than common mild reactions

Question 3 of 10 What best distinguishes scientific evaluation from data presentation in a PSUR?

Scientific evaluation explains what the evidence means and how it affects the regulatory conclusion Scientific evaluation replaces all quantitative analyses with clinical narrative Scientific evaluation focuses only on information received during the current reporting interval Scientific evaluation lists every individual case in greater detail

Question 4 of 10 A potential signal remains under evaluation at the time of PSUR preparation. Which wording is most scientifically appropriate?

The event is an established new risk The event is disproven because no regulatory action has yet occurred The available evidence and limitations are described, while the association remains under evaluation The event should be excluded until the signal is validated

Question 5 of 10 When a PSUR supports a product-information change, what should the report demonstrate?

Only that the change has been proposed by the safety department A traceable relationship between the evidence, risk interpretation, benefit-risk consequence, proposed wording, and applicable regulatory pathway That a separate variation procedure must always be submitted first That the proposed wording is identical to the wording in another product's information

Question 6 of 10 Why should exposure be examined when report counts increase?

Because report counts are meaningful only for products with stable exposure Because an increase in exposure may explain more reports without indicating a higher underlying event rate Because exposure estimates establish causality by themselves Because exposure is relevant only to clinical trial data

Question 7 of 10 What does 'no new signal' most appropriately mean for an important known risk?

There is no need to discuss the risk further The risk has been eliminated The risk should still be assessed for changes in characterisation, frequency, severity, risk factors, and control measures The product's benefit-risk balance is automatically unchanged

Question 8 of 10 What should a strong PSUR conclusion normally communicate?

Only whether a new signal was validated What was found, what it means, how certain the assessment is, and what should happen next Only the preferred regulatory action A single overall numerical estimate of benefit-risk

Question 9 of 10 How should cumulative evidence be used in a current PSUR?

Only the current reporting interval should determine the conclusion Previous conclusions should be copied unless a formal signal is identified New findings should be assessed for whether they strengthen, weaken, confirm, refine, or leave unchanged the previous understanding Older evidence should be excluded to avoid double counting

Question 10 of 10 Which conclusion is most appropriate when a safety concern is not established but remains unresolved?

The concern is confirmed and should be added immediately as an established risk The concern is irrelevant because evidence is insufficient The available evidence does not currently establish an association, and continued monitoring or investigation is warranted for specified reasons The absence of a validated signal proves that no concern exists

Knowledge Assessment: Writing the PSUR Safety Evaluation

Cookie Settings